Aiming at the Right Targets on Drug Price Reform

Journal of Law, Medicine and Ethics 51 (S2):55-57 (2023)
  Copy   BIBTEX

Abstract

A lack of transparency and concerns over patients costs at the pharmacy counter have increased Congressional focus on pharmacy benefits management practices. However, applying regulations without transparency into pharmacy benefits managers practices could do more harm than good.

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 100,733

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Addressing High Drug Prices by Reforming Pharmacy Benefit Managers.Benjamin N. Rome - 2023 - Journal of Law, Medicine and Ethics 51 (S2):46-51.
Pharmacy Benefit Management: The Cost of Drug Price Rebates.James C. Robinson - 2023 - Journal of Law, Medicine and Ethics 51 (S2):52-54.
Ethical issues in the use of electronic health records for pharmacy medicines sales.Richard Cooper - 2007 - Journal of Information, Communication and Ethics in Society 5 (1):7-19.
Professional values in community and public health pharmacy.David Badcott - 2011 - Medicine, Health Care and Philosophy 14 (2):187-194.
Internet Pharmacies: Regulation of a Growing Industry.Amy J. Oliver - 2000 - Journal of Law, Medicine and Ethics 28 (1):98-101.

Analytics

Added to PP
2024-03-05

Downloads
16 (#1,181,785)

6 months
6 (#835,286)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references